[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE372128T1 - Angiogene proteine aus onchocerca volvulus sowie deren verwendung - Google Patents

Angiogene proteine aus onchocerca volvulus sowie deren verwendung

Info

Publication number
ATE372128T1
ATE372128T1 AT01920807T AT01920807T ATE372128T1 AT E372128 T1 ATE372128 T1 AT E372128T1 AT 01920807 T AT01920807 T AT 01920807T AT 01920807 T AT01920807 T AT 01920807T AT E372128 T1 ATE372128 T1 AT E372128T1
Authority
AT
Austria
Prior art keywords
asp
tissue
factor
present
angiogenic proteins
Prior art date
Application number
AT01920807T
Other languages
English (en)
Inventor
Sara Lustigman
Eric Pearlman
Thomas Unnasch
Original Assignee
New York Blood Ct Inc
Univ Case Western Reserve
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Ct Inc, Univ Case Western Reserve, Uab Research Foundation filed Critical New York Blood Ct Inc
Application granted granted Critical
Publication of ATE372128T1 publication Critical patent/ATE372128T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01920807T 2000-04-03 2001-03-27 Angiogene proteine aus onchocerca volvulus sowie deren verwendung ATE372128T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/541,759 US6723322B1 (en) 2000-04-03 2000-04-03 Angiogenic Onchocerca volvulus proteins and uses thereof

Publications (1)

Publication Number Publication Date
ATE372128T1 true ATE372128T1 (de) 2007-09-15

Family

ID=24160920

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01920807T ATE372128T1 (de) 2000-04-03 2001-03-27 Angiogene proteine aus onchocerca volvulus sowie deren verwendung

Country Status (7)

Country Link
US (1) US6723322B1 (de)
EP (1) EP1267917B1 (de)
AT (1) ATE372128T1 (de)
AU (2) AU4782501A (de)
CA (1) CA2403985C (de)
DE (1) DE60130326T2 (de)
WO (1) WO2001074385A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2549669T3 (es) 2004-06-15 2015-10-30 The New York Blood Center, Inc. Propiedades de coadyuvancia y potenciación inmunitaria de productos naturales de Onchocerca volvulus
WO2007111333A1 (ja) * 2006-03-29 2007-10-04 Toyo Boseki Kabushiki Kaisha 核酸導入時の細胞障害を低減する方法
US20190069528A1 (en) * 2016-03-21 2019-03-07 The George Washington University Engineered human hookworms as a novel biodelivery system for vaccines and biologicals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177401B1 (en) 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis

Also Published As

Publication number Publication date
WO2001074385A1 (en) 2001-10-11
DE60130326D1 (de) 2007-10-18
AU4782501A (en) 2001-10-15
EP1267917B1 (de) 2007-09-05
DE60130326T2 (de) 2008-05-29
US6723322B1 (en) 2004-04-20
CA2403985A1 (en) 2001-10-11
EP1267917A1 (de) 2003-01-02
CA2403985C (en) 2012-05-29
EP1267917A4 (de) 2004-06-09
AU2001247825B2 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
ATE277034T1 (de) Liponsaürederivate und deren verwendung bei der behandlung von krankheiten
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
DE69925024D1 (de) Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten
CY1107453T1 (el) Baff, σχετικοι δεσμευτικοι παραγοντες και χρηση αυτων στη διεγερση και αναστολη β-κυτταρων και ανοσοσφαιρινων σε ανοσοαποκρισεις
ATE358718T1 (de) Integrin antagonisten
DE60237431D1 (de) Rezeptor-selektive cannabimimetische aminoalkylindole
ATE384732T1 (de) Vegi, ein inhibitor der angiogenese und des tumorwachstums
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
TR200102020T2 (tr) Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler.
DE69737397D1 (de) Verwendung von mif-antagonisten zur krebstherapie
ATE336485T1 (de) Substituierte heterocyclen und deren verwendung in arzneimitteln
DE60123232D1 (de) Tamandarin und didemnin analoga und methoden zu deren herstellung und verwendung
BRPI0410467A (pt) composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)
AR021946A1 (es) Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
ATE395433T1 (de) Screeningverfahren für geeignete wirkstoffe
BR9906926A (pt) Composições e métodos para tratamento de células tendo dna de minuto duplo
ATE460166T1 (de) Chinazolinderivate und ihre verwendung bei der behandlung von thrombocythämie
ATE413392T1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
ATE372128T1 (de) Angiogene proteine aus onchocerca volvulus sowie deren verwendung
DE60328931D1 (de) Wässrige Zubereitungen von Perfluoropolyetherphosphaten und ihre Verwendung für die ölabweisende Behandlung von Papier
NO20060420L (no) 2-aminobenzoylderivater
DK1051491T3 (da) Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf
FR2872431B1 (fr) Utilisation de fibroplastes gingivaux en therapie cellulaire vasculaire
DE60113968D1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties